v3.26.1
Equity Method Investments (Details) - USD ($)
2 Months Ended 12 Months Ended
Feb. 26, 2025
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Feb. 09, 2023
Equity Method Investment [Line Items]          
Equity method investments, net   $ 10,636,544    
Purchased interests   20,666,667      
Cash   109,091 2,658,182    
Preferred stock, value      
Cost of investment         $ 19,460,000
Amortization expense   2,158,167      
Loss from equity method investment   392,677 (846,588)    
Distribution of earnings   1,745,000      
Intangible assets     8,725,712    
Goodwill   $ 12,808,197    
Customer Relationships [Member]          
Equity Method Investment [Line Items]          
Estimated useful life   15 years      
Series B Preferred Stock [Member]          
Equity Method Investment [Line Items]          
Equity method investments, net $ 11,000,000        
Preferred stock, value   $ 11,000,000    
Issuance shares (in Shares)   0 11,000    
Conversion price per share (in Dollars per share)   $ 56.7      
Series B Convertible Preferred Stock [Member]          
Equity Method Investment [Line Items]          
Equity method investments, net       $ 11,029,221  
Preferred stock, value   $ 1,000      
Conversion price per share (in Dollars per share)   $ 56.7      
Aggregate of common stock (in Shares)   194,004      
Laboratory Services MSO [Member]          
Equity Method Investment [Line Items]          
Ownership percentage 40.00% 40.00%      
Cash   $ 9,000,000      
Amortization expense $ 111,156   $ 666,932    
Impairment loss     259,579    
Loss from equity method investment 503,833   79,923    
Distribution of earnings $ 0   $ 611,888    
Avalon Lab [Member]          
Equity Method Investment [Line Items]          
Total ownership percentage 40.00%        
Avalon Lab [Member] | Series B Preferred Stock [Member]          
Equity Method Investment [Line Items]          
Preferred stock, value   $ 11,000,000      
Issuance shares (in Shares)   11,000      
Avalon Lab [Member] | Series B Stated Value [Member]          
Equity Method Investment [Line Items]          
Preferred stock, value   $ 1,000      
Unrelated Company [Member]          
Equity Method Investment [Line Items]          
Total ownership percentage 60.00%        
Series B Stated Value [Member]          
Equity Method Investment [Line Items]          
Equity method investment payable   $ 666,667